Annual SG&A
$6.09 B
+$417.00 M+7.35%
31 December 2023
Summary:
Gilead Sciences annual selling, general & administrative expenses is currently $6.09 billion, with the most recent change of +$417.00 million (+7.35%) on 31 December 2023. During the last 3 years, it has risen by +$939.00 million (+18.23%). GILD annual SG&A is now at all-time high.GILD Selling, General & Administrative Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly SG&A
$1.43 B
+$56.00 M+4.07%
30 September 2024
Summary:
Gilead Sciences quarterly selling, general & administrative expenses is currently $1.43 billion, with the most recent change of +$56.00 million (+4.07%) on 30 September 2024. Over the past year, it has increased by +$118.00 million (+8.97%). GILD quarterly SG&A is now -29.06% below its all-time high of $2.02 billion, reached on 31 December 2022.GILD Quarterly SG&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM SG&A
$49.20 B
-$4.93 B-9.11%
30 September 2024
Summary:
Gilead Sciences TTM selling, general & administrative expenses is currently $49.20 billion, with the most recent change of -$4.93 billion (-9.11%) on 30 September 2024. Over the past year, it has increased by +$42.70 billion (+656.54%). GILD TTM SG&A is now -41.49% below its all-time high of $6.50 billion, reached on 30 September 2023.GILD TTM SG&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
GILD Selling, General & Administrative Expenses Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +7.3% | +9.0% | +656.5% |
| 3 y3 years | +18.2% | +20.4% | +823.7% |
| 5 y5 years | +50.1% | +36.2% | +1042.0% |
GILD Selling, General & Administrative Expenses High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | at high | +18.2% | -29.1% | +32.3% | -22.6% | at low |
| 5 y | 5 years | at high | +50.1% | -29.1% | +36.2% | -35.4% | at low |
| alltime | all time | at high | >+9999.0% | -29.1% | +9169.6% | -41.5% | +1964.3% |
Gilead Sciences Selling, General & Administrative Expenses History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $1.43 B(+4.1%) | $5.79 B(+2.1%) |
| June 2024 | - | $1.38 B(+0.1%) | $5.67 B(-7.7%) |
| Mar 2024 | - | $1.38 B(-14.5%) | $6.15 B(+0.9%) |
| Dec 2023 | $6.09 B(+7.4%) | $1.61 B(+22.3%) | $6.09 B(-6.3%) |
| Sept 2023 | - | $1.31 B(-28.9%) | $6.50 B(+1.6%) |
| June 2023 | - | $1.85 B(+40.2%) | $6.40 B(+8.3%) |
| Mar 2023 | - | $1.32 B(-34.7%) | $5.91 B(+4.2%) |
| Dec 2022 | $5.67 B(+8.1%) | $2.02 B(+66.5%) | $5.67 B(+7.0%) |
| Sept 2022 | - | $1.21 B(-10.6%) | $5.30 B(+0.4%) |
| June 2022 | - | $1.36 B(+25.3%) | $5.28 B(+0.1%) |
| Mar 2022 | - | $1.08 B(-34.4%) | $5.27 B(+0.5%) |
| Dec 2021 | $5.25 B(+1.8%) | $1.65 B(+38.7%) | $5.25 B(-1.5%) |
| Sept 2021 | - | $1.19 B(-11.9%) | $5.33 B(+1.6%) |
| June 2021 | - | $1.35 B(+28.1%) | $5.24 B(+2.2%) |
| Mar 2021 | - | $1.05 B(-39.0%) | $5.13 B(-0.4%) |
| Dec 2020 | $5.15 B(+17.6%) | $1.73 B(+56.4%) | $5.15 B(+11.4%) |
| Sept 2020 | - | $1.11 B(-10.7%) | $4.63 B(+1.2%) |
| June 2020 | - | $1.24 B(+15.1%) | $4.57 B(+3.3%) |
| Mar 2020 | - | $1.08 B(-10.6%) | $4.43 B(+1.0%) |
| Dec 2019 | $4.38 B(+8.0%) | $1.20 B(+14.4%) | $4.38 B(+1.7%) |
| Sept 2019 | - | $1.05 B(-3.9%) | $4.31 B(+2.5%) |
| June 2019 | - | $1.09 B(+6.3%) | $4.20 B(+2.8%) |
| Mar 2019 | - | $1.03 B(-8.9%) | $4.09 B(+0.8%) |
| Dec 2018 | $4.06 B(+4.6%) | $1.13 B(+19.3%) | $4.06 B(-2.9%) |
| Sept 2018 | - | $948.00 M(-3.3%) | $4.18 B(+1.7%) |
| June 2018 | - | $980.00 M(-1.7%) | $4.11 B(+2.1%) |
| Mar 2018 | - | $997.00 M(-20.4%) | $4.03 B(+3.8%) |
| Dec 2017 | $3.88 B(+14.1%) | $1.25 B(+42.4%) | $3.88 B(+7.2%) |
| Sept 2017 | - | $879.00 M(-2.0%) | $3.62 B(+1.3%) |
| June 2017 | - | $897.00 M(+5.5%) | $3.57 B(+0.2%) |
| Mar 2017 | - | $850.00 M(-14.3%) | $3.56 B(+4.9%) |
| Dec 2016 | $3.40 B(-0.8%) | $992.00 M(+19.4%) | $3.40 B(-2.1%) |
| Sept 2016 | - | $831.00 M(-6.6%) | $3.47 B(-2.0%) |
| June 2016 | - | $890.00 M(+29.9%) | $3.54 B(+2.3%) |
| Mar 2016 | - | $685.00 M(-35.7%) | $3.47 B(+1.2%) |
| Dec 2015 | $3.43 B(+14.9%) | $1.07 B(+18.1%) | $3.43 B(+5.9%) |
| Sept 2015 | - | $903.00 M(+11.2%) | $3.24 B(-1.3%) |
| June 2015 | - | $812.00 M(+25.9%) | $3.28 B(+6.4%) |
| Mar 2015 | - | $645.00 M(-26.4%) | $3.08 B(+3.3%) |
| Dec 2014 | $2.98 B(+75.6%) | $876.00 M(-7.3%) | $2.98 B(+13.9%) |
| Sept 2014 | - | $945.00 M(+53.9%) | $2.62 B(+25.9%) |
| June 2014 | - | $614.00 M(+12.0%) | $2.08 B(+11.2%) |
| Mar 2014 | - | $548.00 M(+6.9%) | $1.87 B(+10.2%) |
| Dec 2013 | $1.70 B(+16.3%) | $512.85 M(+26.1%) | $1.70 B(+9.5%) |
| Sept 2013 | - | $406.86 M(+0.5%) | $1.55 B(+6.0%) |
| June 2013 | - | $404.99 M(+8.2%) | $1.46 B(+5.2%) |
| Mar 2013 | - | $374.30 M(+2.3%) | $1.39 B(-4.7%) |
| Dec 2012 | $1.46 B(+17.6%) | $365.79 M(+14.5%) | $1.46 B(+1.4%) |
| Sept 2012 | - | $319.58 M(-3.9%) | $1.44 B(+1.7%) |
| June 2012 | - | $332.50 M(-25.0%) | $1.42 B(+2.0%) |
| Mar 2012 | - | $443.12 M(+28.0%) | $1.39 B(+11.9%) |
| Dec 2011 | $1.24 B(+18.9%) | $346.22 M(+17.0%) | $1.24 B(+5.6%) |
| Sept 2011 | - | $295.93 M(-2.7%) | $1.18 B(+4.0%) |
| June 2011 | - | $304.27 M(+2.9%) | $1.13 B(+5.2%) |
| Mar 2011 | - | $295.57 M(+5.5%) | $1.07 B(+2.9%) |
| Dec 2010 | $1.04 B(+10.3%) | $280.21 M(+11.8%) | $1.04 B(+2.6%) |
| Sept 2010 | - | $250.56 M(+1.0%) | $1.02 B(+2.3%) |
| June 2010 | - | $248.01 M(-6.6%) | $994.95 M(-1.3%) |
| Mar 2010 | - | $265.62 M(+4.6%) | $1.01 B(+6.5%) |
| Dec 2009 | $946.69 M(+18.7%) | $253.90 M(+11.6%) | $946.69 M(+6.8%) |
| Sept 2009 | - | $227.43 M(-13.0%) | $886.45 M(+4.5%) |
| June 2009 | - | $261.41 M(+28.2%) | $848.22 M(+5.2%) |
| Mar 2009 | - | $203.95 M(+5.3%) | $806.34 M(+1.1%) |
| Dec 2008 | $797.34 M | $193.66 M(+2.4%) | $797.34 M(+1.7%) |
| Sept 2008 | - | $189.19 M(-13.8%) | $783.73 M(+2.1%) |
| June 2008 | - | $219.53 M(+12.6%) | $767.49 M(+4.5%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2008 | - | $194.96 M(+8.3%) | $734.14 M(+4.0%) |
| Dec 2007 | $705.74 M(+23.0%) | $180.05 M(+4.1%) | $705.74 M(+4.9%) |
| Sept 2007 | - | $172.96 M(-7.1%) | $672.79 M(+6.4%) |
| June 2007 | - | $186.18 M(+11.8%) | $632.36 M(+5.8%) |
| Mar 2007 | - | $166.56 M(+13.2%) | $597.75 M(+4.2%) |
| Dec 2006 | $573.66 M(+50.5%) | $147.09 M(+11.0%) | $573.66 M(+7.6%) |
| Sept 2006 | - | $132.53 M(-12.6%) | $533.08 M(+6.3%) |
| June 2006 | - | $151.57 M(+6.4%) | $501.43 M(+12.8%) |
| Mar 2006 | - | $142.47 M(+33.8%) | $444.67 M(+16.6%) |
| Dec 2005 | $381.28 M(+24.2%) | $106.52 M(+5.6%) | $381.28 M(+4.6%) |
| Sept 2005 | - | $100.87 M(+6.4%) | $364.49 M(+8.5%) |
| June 2005 | - | $94.81 M(+19.9%) | $335.99 M(+6.7%) |
| Mar 2005 | - | $79.09 M(-11.9%) | $314.97 M(+2.6%) |
| Dec 2004 | $307.10 M(+22.8%) | $89.72 M(+24.0%) | $307.10 M(-0.1%) |
| Sept 2004 | - | $72.37 M(-1.9%) | $307.40 M(+4.4%) |
| June 2004 | - | $73.79 M(+3.6%) | $294.31 M(+6.6%) |
| Mar 2004 | - | $71.21 M(-20.9%) | $276.20 M(+9.4%) |
| Dec 2003 | $250.16 M(+38.0%) | $90.03 M(+51.9%) | $252.58 M(+14.7%) |
| Sept 2003 | - | $59.28 M(+6.5%) | $220.17 M(+8.3%) |
| June 2003 | - | $55.67 M(+17.0%) | $203.20 M(+7.4%) |
| Mar 2003 | - | $47.59 M(-17.4%) | $189.13 M(+4.3%) |
| Dec 2002 | $181.30 M(+44.9%) | $57.62 M(+36.2%) | $181.30 M(+9.8%) |
| Sept 2002 | - | $42.32 M(+1.7%) | $165.16 M(+6.6%) |
| June 2002 | - | $41.60 M(+4.6%) | $154.89 M(+8.3%) |
| Mar 2002 | - | $39.76 M(-4.1%) | $142.99 M(+14.3%) |
| Dec 2001 | $125.14 M(+52.6%) | $41.48 M(+29.4%) | $125.14 M(+17.9%) |
| Sept 2001 | - | $32.05 M(+7.9%) | $106.18 M(+11.0%) |
| June 2001 | - | $29.71 M(+35.6%) | $95.65 M(+11.8%) |
| Mar 2001 | - | $21.91 M(-2.7%) | $85.56 M(+4.8%) |
| Dec 2000 | $82.02 M(+4.8%) | $22.52 M(+4.7%) | $81.62 M(+39.0%) |
| Sept 2000 | - | $21.52 M(+9.7%) | $58.70 M(-18.2%) |
| June 2000 | - | $19.62 M(+9.2%) | $71.79 M(-2.6%) |
| Mar 2000 | - | $17.97 M(-4592.5%) | $73.73 M(-5.0%) |
| Dec 1999 | $78.30 M(+0.1%) | -$400.00 K(-101.2%) | $77.59 M(-22.1%) |
| Sept 1999 | - | $34.60 M(+60.5%) | $99.59 M(+18.4%) |
| June 1999 | - | $21.56 M(-1.2%) | $84.09 M(+18.6%) |
| Mar 1999 | - | $21.83 M(+1.1%) | $70.93 M(+27.1%) |
| Dec 1998 | $78.20 M(+10.8%) | $21.60 M(+13.1%) | $55.80 M(-35.3%) |
| Sept 1998 | - | $19.10 M(+127.4%) | $86.30 M(+17.6%) |
| June 1998 | - | $8.40 M(+25.4%) | $73.40 M(+3.2%) |
| Mar 1998 | - | $6.70 M(-87.1%) | $71.10 M(+0.9%) |
| Dec 1997 | $70.60 M(+164.4%) | $52.10 M(+740.3%) | $70.50 M(+179.8%) |
| Sept 1997 | - | $6.20 M(+1.6%) | $25.20 M(-5.3%) |
| June 1997 | - | $6.10 M(0.0%) | $26.60 M(-4.7%) |
| Mar 1997 | - | $6.10 M(-10.3%) | $27.90 M(+4.9%) |
| Dec 1996 | $26.70 M(-23.1%) | $6.80 M(-10.5%) | $26.60 M(+34.3%) |
| Sept 1996 | - | $7.60 M(+2.7%) | $19.80 M(+32.0%) |
| June 1996 | - | $7.40 M(+54.2%) | $15.00 M(+50.0%) |
| Mar 1996 | - | $4.80 M(+71.4%) | $10.00 M(-3.8%) |
| Dec 1995 | $34.70 M(+257.7%) | - | - |
| Sept 1995 | - | $2.80 M(+16.7%) | $10.40 M(+4.0%) |
| June 1995 | - | $2.40 M(-14.3%) | $10.00 M(+3.1%) |
| Mar 1995 | - | $2.80 M(+16.7%) | $9.70 M(-209.0%) |
| Mar 1995 | $9.70 M(+27.6%) | - | - |
| Dec 1994 | - | $2.40 M(0.0%) | -$8.90 M(+242.3%) |
| Sept 1994 | - | $2.40 M(+14.3%) | -$2.60 M(-192.9%) |
| June 1994 | - | $2.10 M(-113.3%) | $2.80 M(-62.7%) |
| Mar 1994 | $7.60 M(-66.1%) | -$15.80 M(-281.6%) | $7.50 M(-76.0%) |
| Dec 1993 | - | $8.70 M(+11.5%) | $31.20 M(+10.2%) |
| Sept 1993 | - | $7.80 M(+14.7%) | $28.30 M(+12.3%) |
| June 1993 | - | $6.80 M(-13.9%) | $25.20 M(+13.0%) |
| Mar 1993 | $22.40 M(+146.2%) | $7.90 M(+36.2%) | $22.30 M(+54.9%) |
| Dec 1992 | - | $5.80 M(+23.4%) | $14.40 M(+67.4%) |
| Sept 1992 | - | $4.70 M(+20.5%) | $8.60 M(+120.5%) |
| June 1992 | - | $3.90 M | $3.90 M |
| Mar 1992 | $9.10 M(+49.2%) | - | - |
| Mar 1991 | $6.10 M | - | - |
FAQ
- What is Gilead Sciences annual selling, general & administrative expenses?
- What is the all time high annual SG&A for Gilead Sciences?
- What is Gilead Sciences annual SG&A year-on-year change?
- What is Gilead Sciences quarterly selling, general & administrative expenses?
- What is the all time high quarterly SG&A for Gilead Sciences?
- What is Gilead Sciences quarterly SG&A year-on-year change?
- What is Gilead Sciences TTM selling, general & administrative expenses?
- What is the all time high TTM SG&A for Gilead Sciences?
- What is Gilead Sciences TTM SG&A year-on-year change?
What is Gilead Sciences annual selling, general & administrative expenses?
The current annual SG&A of GILD is $6.09 B
What is the all time high annual SG&A for Gilead Sciences?
Gilead Sciences all-time high annual selling, general & administrative expenses is $6.09 B
What is Gilead Sciences annual SG&A year-on-year change?
Over the past year, GILD annual selling, general & administrative expenses has changed by +$417.00 M (+7.35%)
What is Gilead Sciences quarterly selling, general & administrative expenses?
The current quarterly SG&A of GILD is $1.43 B
What is the all time high quarterly SG&A for Gilead Sciences?
Gilead Sciences all-time high quarterly selling, general & administrative expenses is $2.02 B
What is Gilead Sciences quarterly SG&A year-on-year change?
Over the past year, GILD quarterly selling, general & administrative expenses has changed by +$118.00 M (+8.97%)
What is Gilead Sciences TTM selling, general & administrative expenses?
The current TTM SG&A of GILD is $49.20 B
What is the all time high TTM SG&A for Gilead Sciences?
Gilead Sciences all-time high TTM selling, general & administrative expenses is $6.50 B
What is Gilead Sciences TTM SG&A year-on-year change?
Over the past year, GILD TTM selling, general & administrative expenses has changed by +$42.70 B (+656.54%)